Peter Eyvazzadeh, MD
Orthopaedic Surgery · Nashua, NHNPI 1356752810
Payments from drug & device makers
What this record shows
This record is dominated by education: $14,188 of the $18,722 with a category attached, or 75.8%. 18 manufacturers reported payments, led by Kairos Surgical Inc at 49.8% of the total. Reporting peaked in 2021 at $9,901 and has fallen 96.7% since, to $323 in 2025.
Across 89 payments — averaging $210.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$9K
- Arthrex$4K
- Smith+Nephew$2K
- Liberty Surgical Inc.$1K
- Medical Device Business Services, Inc.$935
- Zimmer Biomet$212
- plus $792 from 12 others
What the payments were for
- Travel & lodging$2,49513%
- Food & beverage$2,03911%
- Education$14,18876%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 20 | $9,326 |
| Arthrex | 26 | $4,022 |
| Smith+Nephew | 3 | $2,333 |
| Liberty Surgical Inc. | 1 | $1,104 |
| Medical Device Business Services, Inc. | 8 | $935 |
| Zimmer Biomet | 3 | $212 |
| Ferring Pharmaceuticals Inc. | 6 | $134 |
| Pacira Pharmaceuticals Incorporated | 5 | $119 |
| Endo USA, Inc. | 4 | $106 |
| Stryker | 3 | $95 |
| AstraZeneca | 1 | $89 |
| Innovation Technologies Inc | 1 | $70 |
| Boston Scientific | 1 | $50 |
| Supreme Orthopedic Systems, LLC | 2 | $36 |
| Orthofix Medical, Inc. | 2 | $30 |
| Bioventus LLC | 1 | $26 |
| Vertex | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,722 in reported general payments places this provider in the 80th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 15 | $58 |
| Meloxicam | 18 | $33 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Nashua
- David RichardsNashua$122K
- Christian KlareNashua$88K
- Matthew WilkeningNashua$79K
- Thomas FortneyNashua$54K
- Anand PadmanabhaNashua$16K
- Bryan BeanNashua$11K
- Andrew GarberNashua$9K
- Jason SmoakNashua$8K
- James BargerNashua$7K
- Daniel BouvierNashua$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.